Expertise in
1
conditions

Delphine Ciron-Larrieu

Oncopole Claudius Regaud, Toulouse IUCT Oncopole
Toulouse, FR 
Expertise in
1
conditions
Oncopole Claudius Regaud, Toulouse IUCT Oncopole
Toulouse, FR 

Overview

Delphine Ciron-Larrieu practices practicing medicine in Toulouse, France.

Ms. Ciron-Larrieu is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Oligodendroglioma, Gliomatosis Cerebri, Glioma, and Brain Tumor.

She is actively involved in clinical research, co-authoring 15 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Oncopole Claudius Regaud, Toulouse IUCT Oncopole
Toulouse, 31100, France
Other Locations
Nimes, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
Enrollment Status: Active_not_recruiting
Publish Date: April 15, 2026
Intervention Type: Drug
Study Drugs: Berubicin, Lomustine
Study Phase: Phase 2
A Multicentric, Prospective Cohort Study Aiming to Evaluate the Added Value of a Large Molecular Profiling Panel (Panel FoundationOne) Versus a Limited Molecular Profiling Panel (Panel CONTROL) in Advanced Solid Tumors.
A Multicentric, Prospective Cohort Study Aiming to Evaluate the Added Value of a Large Molecular Profiling Panel (Panel FoundationOne) Versus a Limited Molecular Profiling Panel (Panel CONTROL) in Advanced Solid Tumors.
Enrollment Status: Completed
Publish Date: May 09, 2022
Intervention Type: Genetic
Study Phase: Not Applicable
View 1 Less Clinical Trial

15 Total Publications

BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study.
BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study.
Journal: European journal of endocrinology
Published: April 17, 2024

Frequently Asked Questions about Delphine Ciron-Larrieu

Is Delphine Ciron-Larrieu a top-rated expert for Oligodendroglioma?

MediFind is an objective health platform that identifies experts based on real-world data. Delphine Ciron-Larrieu is classified as an Advanced expert for Oligodendroglioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Delphine Ciron-Larrieu participate in research or clinical trials?

Yes. Delphine Ciron-Larrieu has published 15 articles and abstracts on conditions like Oligodendroglioma. You can view a list of Delphine Ciron-Larrieu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ciron-Larrieu's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile